Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anacetrapib for Heterozygous Familial Hypercholesterolemia (REALIZE)
NCT01524289Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of anacetrapib in familial hypercholesterolemia (FH), sponsored by Merck & Co.. Started Feb 2012; status: completed.
02
Drugs
anacetrapib
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT01524289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524289.